FDA Indications 3-5

Amoxicillin

Acute otitis media

Lower respiratory tract infection

ENT/SSTI, or genitourinary infections

Pharyngitis, tonsillitis (Streptococcal)

H. pylori gastrointestinal tract infection

Amoxicillin; Clavulanate Potassium

Acute otitis media

Lower respiratory tract infection

Sinusitis, SSTI, genitourinary infections

CAP

Cystitis and Pyelonephriits

Azithromycin

Acute infective exacerbation of COPD

SSTI

Bacterial sinusitis

Chancroid, nongonococcal cervicitis/urethritis

CAP

Gonorrhea, urethritis, or cervicitis

Streptococcal pharyngitis

Cefdinir

Acute otitis media

Uncomplicated SSTI

pharyngitis, tonsillitis

CAP

Bronchitis, acute, secondary bacterial infection

Cephalexin

Otitis media

Respiratory tract infection

SSTI

Streptococcal pharyngitis

UTI

Osteomyelitis

Ciprofloxacin

Anthrax, postexposure prophylaxis

chronic Bacterial prostatitis

Bronchitis

Lower respiratory tract infection,

SSTI

Sinusitis

UTI

Clindamycin

Staphylococci, streptococci, pneumococci SSTI

Infectious disease of abdomen

Lower respiratory tract infection

Pelvic inflammatory disease

Septicemia

Osteomyelitis

Diabetic Foot infection

Acne vulgaris

Bacterial vaginosis

Doxycycline

Acinetobacter infection

Acne vulgaris

uncomplicated Gonorrhea,

Staphylococcal SSTI

CAP

Levofloxacin

Chronic Bacterial prostatitis

Acute Bacterial sinusitis

Acute/chronic Bronchitis

CAP

SSTI

acute Pyelonephritis

Nitrofurantoin

Urinary tract infection (treatment and prophylaxis)

Sulfamethoxazole; Trimethoprim

Acute infective exacerbation of COPD

HIV infection, Pneumocystis pneumonia (treatment and prophylaxis)

Traveler’s diarrhea

Urinary tract infection